Academic Achievements

At Divamics, we believe in advancing science to create better therapies.
Explore our scientific contributions, from groundbreaking research to key collaborations, that are shaping the future of drug discovery.

YEARS 2025

Molecular dynamics-guided optimization of BGM0504 enhances dual-target agonism for combating diabete

2024-07-19 00:30:00
The dual activation of glucagon-like peptide-1 receptor (GLP-1R) and glucose-dependent insulinotropic polypeptide receptor (GIPR) has emerged as a promising therapeutic strategy for managing type 2 diabetes and obesity. Tirzepatide, a dual agonist peptide, has exhibited superior clinical efficacy in glycemic and weight control compared to selective GLP-1R agonists.

Molecular Insights on the Conformational Transitions and Activity Regulation of the c-Met Kinase Ind

2023-06-26 21:00:00
The tyrosine-protein kinase Met (c-Met) is an important signaling molecule involved in cellular growth and division. The dysregulation of c-Met may induce many fatal diseases, including non-small cell lung cancer, gastrointestinal cancers, hepatocellular carcinoma, etc.

Interested in academic collaboration or joint research?

Reach out to our scientific team at partner@divamics.com to explore new possibilities together.

Contact Us